Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
This study is currently recruiting participants.
Study NCT00427076 Information provided by Rabin Medical Center
First Received: January 24, 2007 Last Updated: September 17, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Staphylococcal Infections
Meningitis
Sepsis
Pneumonia
Additional conditions recognized in this trial
Communicable Diseases
Infection
More general conditions related to this trial
Bacterial Infections
Central Nervous System Diseases
Central Nervous System Infections
Gram-Positive Bacterial Infections
Inflammation
Lung Diseases
Nervous System Diseases
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Infections
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
Cotrimoxazole
Vancomycin
Additional drug interventions recognized in this trial
Methicillin
Sulfamethoxazole
Trimethoprim
Trimethoprim-Sulfamethoxazole Combination
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Rabin Medical Center
Back to top of Main Content
